Kodikaz is structured around moving from incremental cancer therapies with devastating side-effects to durable cures through targeted therapies that can eradicate cancers completely. The firm's Zip-Code⢠Technology platform is a first in class, cell-specific delivery system that can be used for a broad range of gene therapy applications. Because the Zip-Codes⢠are derived from an endogenous human mechanism, the many challenges of viral delivery approaches are avoided. The Zip-Codes⢠are universally applicable and specific for each cell type. With the firm's approach usefully understood as groundbreaking and pioneering - ushering in a new era of gene therapies., the underpinning science is designed to redefine the boundaries of medicine, fuel new therapeutic approaches - providing a diversity of tools to oncologists and hope to families and patients with ca
